How is high-dose interleukin-2 (IL-2) therapy for skin cancer administered?

High-dose interleukin-2 (IL-2) treatment for skin cancer patients involves the following:
  • Treatment with high-dose IL-2 therapy will require inpatient hospitalization.
  • One cycle of therapy will consist of treatment with IL-2 given in a vein every 8 hours for a maximum of 14 doses as tolerated. This will require a five- to seven-day stay in the hospital.
  • Following approximately 10 to 14 days of rest after discharge from the hospital, patients will be treated again with a second cycle of therapy.
  • These two cycles consist of one course of therapy.
  • Patients will be evaluated for response to therapy two to four weeks after completion of one course of therapy.
  • Additional courses of therapy may be offered dependent upon patient response and tolerance to treatment.

Continue Learning about Anti-HIV Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.